$SRRK
Scholar Rock Holding Corp

2024 Q1 Form 10-K Financial Statement

#000155837024003540 Filed on March 19, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2023
Revenue $0.00 $0.00
YoY Change -100.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $13.07M $49.40M
YoY Change 20.86% 14.56%
% of Gross Profit
Research & Development $43.09M $34.96M $121.9M
YoY Change 44.93% 18.06% -2.04%
% of Gross Profit
Depreciation & Amortization $598.0K $672.0K $2.844M
YoY Change -18.42% -10.28% -4.76%
% of Gross Profit
Operating Expenses $58.42M $48.03M $171.3M
YoY Change 44.21% 18.81% 2.23%
Operating Profit -$58.42M -$171.3M
YoY Change 44.21% 27.48%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $1.566M $1.906M $5.506M
YoY Change 38.58% 62.49% -4271.21%
Pretax Income -$46.13M -$165.8M
YoY Change 17.5% 23.26%
Income Tax
% Of Pretax Income
Net Earnings -$56.85M -$46.13M -$165.8M
YoY Change 44.37% 17.5% 23.26%
Net Earnings / Revenue
Basic Earnings Per Share -$0.59 -$1.99
Diluted Earnings Per Share -$0.59 -$0.50 -$1.99
COMMON SHARES
Basic Shares Outstanding 77.87M 72.14M 83.35M
Diluted Shares Outstanding 95.89M 83.35M

Balance Sheet

Concept 2024 Q1 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $238.4M $279.9M $279.9M
YoY Change -13.39% -11.23% -11.23%
Cash & Equivalents $91.98M $101.9M $101.9M
Short-Term Investments $146.5M $178.1M $178.1M
Other Short-Term Assets $8.501M $8.256M $8.256M
YoY Change -28.41% -34.8% -34.8%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $246.9M $288.2M $288.2M
YoY Change -14.01% -12.14% -12.14%
LONG-TERM ASSETS
Property, Plant & Equipment $4.038M $4.600M $16.02M
YoY Change -39.56% -37.7% -38.22%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $4.102M $4.417M $6.824M
YoY Change 148.15% 156.95% 61.82%
Total Long-Term Assets $20.35M $22.84M $22.84M
YoY Change -26.16% -24.23% -24.23%
TOTAL ASSETS
Total Short-Term Assets $246.9M $288.2M $288.2M
Total Long-Term Assets $20.35M $22.84M $22.84M
Total Assets $267.3M $311.0M $311.0M
YoY Change -15.07% -13.16% -13.16%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.868M $3.465M $3.465M
YoY Change -22.9% -13.24% -13.24%
Accrued Expenses $21.41M $20.45M $27.86M
YoY Change 45.36% -15.92% -13.41%
Deferred Revenue
YoY Change
Short-Term Debt $5.501M $1.334M $1.334M
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $37.51M $32.74M $32.74M
YoY Change 43.11% -10.03% -10.03%
LONG-TERM LIABILITIES
Long-Term Debt $44.59M $48.68M $48.68M
YoY Change -10.51% -2.13% -2.13%
Other Long-Term Liabilities $2.412M $4.392M $4.392M
YoY Change -75.95% -62.78% -62.78%
Total Long-Term Liabilities $44.59M $48.68M $53.08M
YoY Change -10.51% -2.13% -13.76%
TOTAL LIABILITIES
Total Short-Term Liabilities $37.51M $32.74M $32.74M
Total Long-Term Liabilities $44.59M $48.68M $53.08M
Total Liabilities $84.51M $85.82M $85.82M
YoY Change -1.81% -12.37% -12.37%
SHAREHOLDERS EQUITY
Retained Earnings -$733.3M -$676.4M
YoY Change 33.32% 32.47%
Common Stock $80.00K $76.00K
YoY Change 53.85% 46.15%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $182.8M $225.2M $225.2M
YoY Change
Total Liabilities & Shareholders Equity $267.3M $311.0M $311.0M
YoY Change -15.07% -13.16% -13.16%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2023
OPERATING ACTIVITIES
Net Income -$56.85M -$46.13M -$165.8M
YoY Change 44.37% 17.5% 23.26%
Depreciation, Depletion And Amortization $598.0K $672.0K $2.844M
YoY Change -18.42% -10.28% -4.76%
Cash From Operating Activities -$49.79M -$37.35M -$145.2M
YoY Change 15.63% 29.2% 9.44%
INVESTING ACTIVITIES
Capital Expenditures $23.00K $1.000K $71.00K
YoY Change -23.33% -99.15% -93.33%
Acquisitions
YoY Change
Other Investing Activities $33.41M -$25.13M $41.21M
YoY Change -62.89% -13052.58% -124.15%
Cash From Investing Activities $33.38M -$25.13M $41.14M
YoY Change -62.9% -32733.77% -123.96%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $97.71M
YoY Change -49.97%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 6.525M 96.53M 102.6M
YoY Change 506.41% -10051.44% -47.35%
NET CHANGE
Cash From Operating Activities -49.79M -37.35M -145.2M
Cash From Investing Activities 33.38M -25.13M 41.14M
Cash From Financing Activities 6.525M 96.53M 102.6M
Net Change In Cash -9.876M 34.05M -1.511M
YoY Change -120.57% -214.27% -98.62%
FREE CASH FLOW
Cash From Operating Activities -$49.79M -$37.35M -$145.2M
Capital Expenditures $23.00K $1.000K $71.00K
Free Cash Flow -$49.81M -$37.35M -$145.3M
YoY Change 15.61% 28.69% 8.63%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
75979495
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001727196
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
51672579
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
001-38501
CY2023 dei Entity Registrant Name
EntityRegistrantName
SCHOLAR ROCK HOLDING CORP
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
82-3750435
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
301 Binney Street, 3rd Floor
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Cambridge
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02142
CY2023 dei City Area Code
CityAreaCode
857
CY2023 dei Local Phone Number
LocalPhoneNumber
259-3860
CY2023 dei Security12b Title
Security12bTitle
Common Stock
CY2023 dei Trading Symbol
TradingSymbol
SRRK
CY2023 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
158300000
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
77866281
CY2023Q4 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023 dei Auditor Firm
AuditorFirmId
42
CY2023 dei Auditor Name
AuditorName
Ernst & Young LLP
CY2023 dei Auditor Location
AuditorLocation
Boston, Massachusetts
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
101855000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
103275000
CY2023Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
178083000
CY2022Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
212086000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8256000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
12663000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
288194000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
328024000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4600000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7384000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
11417000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
18543000
CY2023Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
2407000
CY2022Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
2498000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4417000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1719000
CY2023Q4 us-gaap Assets
Assets
311035000
CY2022Q4 us-gaap Assets
Assets
358168000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3465000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3994000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
20449000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
24321000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
7408000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
7852000
CY2023Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
1334000
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
85000
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
222000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
32741000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
36389000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4392000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
11800000
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
48684000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
49744000
CY2023Q4 us-gaap Liabilities
Liabilities
85817000
CY2022Q4 us-gaap Liabilities
Liabilities
97933000
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
75979495
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
51672579
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
76000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
52000
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
901471000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
771699000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
92000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-884000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-676421000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-510632000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
225218000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
260235000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
311035000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
358168000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
33193000
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
121900000
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
124444000
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
49395000
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
43119000
CY2023 us-gaap Operating Expenses
OperatingExpenses
171295000
CY2022 us-gaap Operating Expenses
OperatingExpenses
167563000
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-171295000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-134370000
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5506000
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-132000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-165789000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-134502000
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.99
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.26
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
83347086
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
59611656
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-165789000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-134502000
CY2023 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
976000
CY2022 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-849000
CY2023 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
976000
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-849000
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-164813000
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-135351000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
172074000
CY2022 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-849000
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
195315000
CY2022 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
496000
CY2022 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
27701000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-134502000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
260235000
CY2023 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
976000
CY2023 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
97653000
CY2023 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1535000
CY2023 srrk Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
3463000
CY2023 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
27142000
CY2023 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
3000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-165789000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
225218000
CY2023 us-gaap Profit Loss
ProfitLoss
-165789000
CY2022 us-gaap Profit Loss
ProfitLoss
-134502000
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2844000
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2986000
CY2023 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
274000
CY2022 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
720000
CY2023 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-11000
CY2022 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-33000
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
27142000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
27701000
CY2023 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
6220000
CY2022 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
2142000
CY2023 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
7126000
CY2022 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
6899000
CY2023 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-4530000
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
322000
CY2023 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
2698000
CY2022 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
97000
CY2023 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-529000
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-251000
CY2023 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-3927000
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
6889000
CY2023 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-7852000
CY2022 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-7407000
CY2022 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-33193000
CY2023 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-138000
CY2022 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-8000
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-145226000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-132694000
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
71000
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1064000
CY2023 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
13000
CY2023 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
290801000
CY2022 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
300634000
CY2023 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
332000000
CY2022 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
130000000
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
41141000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-171698000
CY2023 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
97709000
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
195315000
CY2023 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
3463000
CY2023 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1399000
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
492000
CY2023 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
3000
CY2022 us-gaap Payments Of Debt Restructuring Costs
PaymentsOfDebtRestructuringCosts
975000
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
102574000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
194832000
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1511000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-109560000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
105773000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
215333000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
104262000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
105773000
CY2023 us-gaap Interest Paid Net
InterestPaidNet
6399000
CY2022 us-gaap Interest Paid Net
InterestPaidNet
4372000
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in accordance with GAAP requires management to make estimates and judgments that may affect the reported amounts of assets and liabilities and related disclosures of contingent assets and liabilities at the date of the financial statements and the related reporting of revenues and expenses during the reporting period. Management bases its estimates on historical experience and on various assumptions that are believed to be reasonable under the circumstances. Actual results could differ from those estimates.</p>
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Concentration of Credit Risk and Off-Balance Sheet Risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 12pt 0pt;"><span style="font-size:10pt;">The Company has no off-balance sheet risk, such as foreign exchange contracts, option contracts or other foreign-hedging arrangements. The Company follows an investment policy approved by the Board of Directors. Its primary objectives are the preservation of capital and maintenance of liquidity. The Company invests only in fixed income instruments denominated and payable in U.S. dollars including obligations of the U.S. government and its agencies and money market funds registered according to SEC Rule 2a-7 of the Investment Company Act of 1940. All securities must have a readily ascertainable market value</span><span style="font-size:7.5pt;">, </span><span style="font-size:10pt;">must be readily marketable and be U.S. dollar denominated.</span></p>
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
101855000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
103275000
CY2023Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
2407000
CY2022Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
2498000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
104262000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
105773000
CY2022 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2023 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2023 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2023Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
177991000
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
93000
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1000
CY2023Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
178083000
CY2022Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
212970000
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
884000
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
212086000
CY2023Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
11900000
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
212100000
CY2023Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
3
CY2023Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
3
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
23
CY2023Q4 srrk Prepaid External Research And Development Expense Current
PrepaidExternalResearchAndDevelopmentExpenseCurrent
4059000
CY2022Q4 srrk Prepaid External Research And Development Expense Current
PrepaidExternalResearchAndDevelopmentExpenseCurrent
7528000
CY2023Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
2486000
CY2022Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
1552000
CY2023Q4 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
1076000
CY2022Q4 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
2735000
CY2023Q4 us-gaap Prepaid Insurance
PrepaidInsurance
635000
CY2022Q4 us-gaap Prepaid Insurance
PrepaidInsurance
848000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8256000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
12663000
CY2023Q4 srrk Prepaid External Research And Development Expense Noncurrent
PrepaidExternalResearchAndDevelopmentExpenseNoncurrent
4074000
CY2022Q4 srrk Prepaid External Research And Development Expense Noncurrent
PrepaidExternalResearchAndDevelopmentExpenseNoncurrent
1422000
CY2023Q4 us-gaap Prepaid Expense Other Noncurrent
PrepaidExpenseOtherNoncurrent
312000
CY2022Q4 us-gaap Prepaid Expense Other Noncurrent
PrepaidExpenseOtherNoncurrent
256000
CY2023Q4 srrk Prepaid Insurance Noncurrent
PrepaidInsuranceNoncurrent
31000
CY2022Q4 srrk Prepaid Insurance Noncurrent
PrepaidInsuranceNoncurrent
41000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4417000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1719000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
15926000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
17615000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
11326000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
10231000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4600000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7384000
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2800000
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3000000.0
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
10591000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
6800000
CY2023Q4 srrk Accrued External Research And Development Expense
AccruedExternalResearchAndDevelopmentExpense
6825000
CY2022Q4 srrk Accrued External Research And Development Expense
AccruedExternalResearchAndDevelopmentExpense
15178000
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
2267000
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1510000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
766000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
833000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
20449000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
24321000
CY2023Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
6.85
CY2023Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
92400000
CY2023Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
43365106
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
27142000
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
27701000
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Incremental Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost
2000000.0
CY2023Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
49131000
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
8328000
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2023 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.063
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.068
CY2023 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
-0.023
CY2022 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
-0.026
CY2023 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
-0.003
CY2023 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
-0.049
CY2022 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
-0.075
CY2023 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.001
CY2022 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.007
CY2023 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.297
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.320
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
110120000
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
93505000
CY2023Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
45621000
CY2022Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
36785000
CY2023Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
49699000
CY2022Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
27446000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
7489000
CY2023Q4 srrk Deferred Tax Assets Operating Lease Liability
DeferredTaxAssetsOperatingLeaseLiability
3217000
CY2022Q4 srrk Deferred Tax Assets Operating Lease Liability
DeferredTaxAssetsOperatingLeaseLiability
5329000
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
3294000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
2579000
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
220279000
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
173133000
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
216524000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
167275000
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
3755000
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
5858000
CY2023Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
3113000
CY2022Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
5029000
CY2023Q4 srrk Deferred Tax Liabilities Fixed And Intangible Assets
DeferredTaxLiabilitiesFixedAndIntangibleAssets
642000
CY2022Q4 srrk Deferred Tax Liabilities Fixed And Intangible Assets
DeferredTaxLiabilitiesFixedAndIntangibleAssets
829000
CY2023Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
3755000
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
5858000
CY2023 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
49200000
CY2022 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
43000000.0
CY2023 us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
81000000.0
CY2023Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
49700000
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2023 us-gaap Sublease Income
SubleaseIncome
2000000.0
CY2022 us-gaap Sublease Income
SubleaseIncome
2700000
CY2023 us-gaap Operating Lease Cost
OperatingLeaseCost
8331000
CY2023 us-gaap Variable Lease Cost
VariableLeaseCost
2105000
CY2023 us-gaap Lease Cost
LeaseCost
10436000
CY2023 us-gaap Operating Lease Payments
OperatingLeasePayments
9057000
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y7M6D
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.076
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
8051000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
4498000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
12549000
CY2023Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
749000
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
11800000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
7408000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4392000
CY2023 us-gaap Operating Lease Expense
OperatingLeaseExpense
8300000
CY2022 us-gaap Operating Lease Expense
OperatingLeaseExpense
8700000
CY2023Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
1389000
CY2023Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
16667000
CY2023Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
16667000
CY2023Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
16277000
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
51000000
CY2023 us-gaap Interest Expense Debt
InterestExpenseDebt
6500000
CY2022 us-gaap Interest Expense Debt
InterestExpenseDebt
4700000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-165789000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-134502000
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
83347086
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
59611656
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.99
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.26
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
19378661
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
18369487
CY2020Q1 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
0.50
CY2020Q1 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
0.06
CY2020Q1 us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.03
CY2023 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
900000
CY2022 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
800000
CY2022Q2 us-gaap Restructuring And Related Cost Number Of Positions Eliminated
RestructuringAndRelatedCostNumberOfPositionsEliminated
39
CY2022Q2 us-gaap Restructuring And Related Cost Number Of Positions Eliminated Period Percent
RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent
0.25
CY2022Q2 us-gaap Restructuring Charges
RestructuringCharges
1900000
CY2022Q2 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
100000

Files In Submission

Name View Source Status
0001558370-24-003540-index-headers.html Edgar Link pending
0001558370-24-003540-index.html Edgar Link pending
0001558370-24-003540.txt Edgar Link pending
0001558370-24-003540-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
srrk-20231231.xsd Edgar Link pending
srrk-20231231x10k.htm Edgar Link pending
srrk-20231231x10k006.jpg Edgar Link pending
srrk-20231231x10k007.jpg Edgar Link pending
srrk-20231231x10k008.jpg Edgar Link pending
srrk-20231231x10k009.jpg Edgar Link pending
srrk-20231231x10k010.jpg Edgar Link pending
srrk-20231231x10k011.jpg Edgar Link pending
srrk-20231231x10k012.jpg Edgar Link pending
srrk-20231231x10k013.jpg Edgar Link pending
srrk-20231231x10k014.jpg Edgar Link pending
srrk-20231231x10k015.jpg Edgar Link pending
srrk-20231231xex10d32.htm Edgar Link pending
srrk-20231231xex10d32001.jpg Edgar Link pending
srrk-20231231xex10d32002.jpg Edgar Link pending
srrk-20231231xex10d8.htm Edgar Link pending
srrk-20231231xex21d1.htm Edgar Link pending
srrk-20231231xex23d1.htm Edgar Link pending
srrk-20231231xex31d1.htm Edgar Link pending
srrk-20231231xex31d2.htm Edgar Link pending
srrk-20231231xex32d1.htm Edgar Link pending
srrk-20231231xex97.htm Edgar Link pending
srrk-20231231_cal.xml Edgar Link unprocessable
srrk-20231231_lab.xml Edgar Link unprocessable
srrk-20231231_pre.xml Edgar Link unprocessable
srrk-20231231x10k_htm.xml Edgar Link completed
srrk-20231231_def.xml Edgar Link unprocessable